spray-freeze-drying-for-biologic-powders
Is your biologic's stability compromised, delaying IND and raising costs? Discover how spray freeze drying can engineer stable, room-temperature powders in a single step, reducing cold chain reliance and accelerating your timeline.
Menu
Your Biologic's Stability Is Compromised. What's Your Next Move?
The Hidden Costs of Formulation Failure
An Action Plan for IND-Ready Powder Formulations
A More Controlled Path Forward[20]:
Your Biologic's Stability Is Compromised. What's Your Next Move?
What if you could engineer a stable, room-temperature biologic powder in a single step, making you less reliant on the cold chain and getting you to IND faster? For many CMC leaders, formulation is a tricky bottleneck, where months are lost to iterative screening and failed stability trials. With nearly half of all Biologics License Applications (BLAs) facing delays due to CMC issues, everyone needs a strong, scalable formulation[1].
The Hidden Costs of Formulation Failure
You've optimized the molecule and locked the cell line. Now, the clock is ticking on your IND submission. Every failed stability run or sign of aggregation pushes your timeline back by months, while temperature excursions during transport threaten product integrity and cost a lot. Failures in temperature-controlled logistics cost the biopharma industry approximately $35 billion annually in lost product, replacement costs, and wasted resources[2]. There's not much room for mistakes.
Freeze-drying has long been the usual way for creating stable biologic powders. The process is really slow, often taking several days, and makes scaling up hard[3, 4, 5]. For complex modalities like viral vectors, mRNA-LNP constructs, and high-concentration monoclonal antibodies, the stresses of traditional freezing can damage the structure[6, 7, 8]. You need a process that not only preserves but also engineers—creating particles optimized for stability, dissolution, and delivery from the very first step[9].
An Action Plan for IND-Ready Powder Formulations
Spray freeze drying (SFD) offers a modern alternative that combines the gentle, low-temperature environment of lyophilization with the particle engineering capabilities of spray drying. This single-step, continuous process provides precise control over particle characteristics, giving you a stable, easy-to-handle powder for your CMC package[10, 7].
Quick Facts: Spray Freeze Drying vs. Conventional Methods
Speed and Efficiency: SFD really cuts down on processing time compared to multi-day lyophilization cycles[13, 14].
Enhanced Stability: The rapid freezing of atomized droplets helps maintain the biologic's native structure by keeping it away from damaging ice crystal interfaces. This is great for delicate molecules[15].
Particle Engineering: SFD produces highly porous, spherical microparticles with a larger surface area, which can help it dissolve faster[10, 7].
Reduced Cold-Chain Burden: Formulations can be optimized for stability at refrigerated or ambient temperatures, making logistics easier and cheaper[16, 17, 18].
A More Controlled Path Forward[20]:
Atomize and Flash-Freeze: Your liquid formulation is first atomized into fine droplets. These droplets are instantly frozen by contact with a cryogenic medium like liquid nitrogen, locking the biologic in a stable, amorphous state and preventing the formation of large ice crystals that can cause damage[21, 22].
Gentle Sublimation: The frozen, spherical particles are then transferred to a dryer where the solvent is removed via sublimation—the same gentle process used in traditional freeze-drying. This increased surface area of the particles allows for heat and mass move around better, shortening drying times.
Deliver a Superior Powder: The result is an even, easy-to-handle powder with consistent particle size and shape[16]. This engineered powder offers easier handling for fill/finish and dissolves quickly and evenly, which is super important for injectable drugs[23].
This technology is not just theoretical; it is a proven way to make stable dry powders for a range of biologics, including proteins, vaccines, and nanoparticles[17, 18]. For instance, Pfizer has explored SFD to really shorten the lyophilization cycle for mRNA-LNP formulations from several days to under two hours[16].
Gain Control Over Your CMC Timelines[14]
Your path to the clinic does not have to be defined by formulation delays and stability risks. By moving beyond conventional drying methods, you can make a critical step less risky in your development pipeline. Control particle attributes, enhance stability, and accelerate your CMC package with a proven, scalable technology made for today’s complex biologics.
Schedule a strategy call with our formulation experts—accelerate CMC, reduce risk, and move forward with confidence.
[Contact Our Experts]
IND-ready
De-risked
Scale-tested
Room-temp optimized
No guesswork
